Myda Advisors LLC Shockwave Medical, Inc. Transaction History

Myda Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$191.17 - $325.63 $191,170 - $325,630	1,000 New	1,000 $325,000
Q3 2023 Nov 14, 2023	BUY	$194.33 - $283.97 $971,650 - $1.42 Million	5,000 New	5,000 $995,000
Q2 2022 Aug 12, 2022	SELL	$115.91 - $214.48 $231,820 - $428,960	-2,000 Reduced 50.0%	2,000 $382,000
Q1 2022 May 13, 2022	SELL	$127.96 - $207.36 $127,960 - $207,360	-1,000 Reduced 20.0%	4,000 $829,000
Q4 2021 Feb 11, 2022	SELL	$165.13 - $241.83 $412,825 - $604,575	-2,500 Reduced 33.33%	5,000 $892,000
Q3 2021 Nov 12, 2021	SELL	$163.99 - $235.57 $81,995 - $117,785	-500 Reduced 6.25%	7,500 $1.54 Million
Q2 2021 Aug 13, 2021	SELL	$131.45 - $201.49 $262,900 - $402,980	-2,000 Reduced 20.0%	8,000 $1.52 Million
Q4 2020 Feb 12, 2021	BUY	$67.44 - $103.72 $674,400 - $1.04 Million	10,000 New	10,000 $1.04 Million
Q4 2019 Feb 13, 2020	SELL	$29.4 - $44.98 $382,200 - $584,740	-13,000 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$29.71 - $55.23 $386,230 - $717,990	13,000 New	13,000 $389,000

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Myda Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Myda Advisors LLC with notifications on news.